Monday, May 23, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

The need for a holistic and unbiased approach to develop a more universal vaccine for coronaviruses

by Medical Finance
in Coronavirus
Study: Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses. Image Credit: Natalypaint/Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

In a recent perspective article published in Nature Immunology, researchers emphasized the need to take on a holistic and unbiased approach to develop a universal vaccine for coronaviruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is a biomedical priority during the ongoing coronavirus disease 2019 (COVID-19) pandemic.

Study: Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses. Image Credit: Natalypaint/Shutterstock
Study: Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses. Image Credit: Natalypaint/Shutterstock

Additionally, they discussed the ideas for generating long-lived, protective immune responses in the vaccinated population that remain undisturbed by genetic and environmental factors, such as age, sex, diet, geographical location, microbiome composition, and metabolites.

Developing an understanding of the innate immune response and host environmental factors that shape the broad and long-term cellular and humoral immune responses that contribute to the heterogeneity in COVID-19 vaccine responses is crucial for developing the next-generation vaccines.

Defining these mechanisms could lead to a universal vaccine that utilizes both arms of the immunity, humoral and cellular, to combat COVID-19. It could protect against future SARS-CoV-2 variants and perhaps other coronavirus strains to control the ongoing COVID-19 pandemic and prevent future ones.

The whole endeavor relies on an increased understanding of the innate immune system and the development of complementing and optimized immunogens, vectors, and adjuvants for next-generation COVID-19 vaccines.

Vaccine-induced immunity: How it works?

In an established vaccine response, antigen-presenting cells (APCs) of innate immunity encounter vaccine antigen at the immunization site and present it to T and B lymphocytes. The immune response of the cross-talk among APCs, T, and B cells is shaped partially by the vaccine vector, immunogen, and adjuvant and partly by the host environment.

Nevertheless, it initiates the innate immune signaling cascades, including retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs), toll-like receptors (TLRs), nucleotide oligomerization domain (NOD)-like receptors (NLRs)), and deoxyribonucleic acid (DNA) sensors.

These cascades trigger discrete transcriptional networks mainly in dendritic cells (DCs) and macrophages, thus modulating the magnitude and the quality of the adaptive immune response, specifically, B cell maturation and antibody isotype switching to vaccines. The balance of these signals determines the degree of boosting of any preexisting immunity.

Identifying the right cascade pathway and effectively targeting the same is crucial for designing a better vaccine strategy. Regarding targeting it therapeutically, innate immunity is again easier to target compared to adaptive immunity, where factors such as human leukocyte antigen (HLA) background and prior exposures can result in highly variable vaccine outcomes.

Further, the authors recommended some ways to directly target innate immunity via vaccination, such as:

  1. using different adjuvants or altering the immunogenic component(s) of vaccines, for instance, the CpG motifs (or pathogen-associated molecular patterns (PAMPs)) in DNA vaccines;
  2. ii) target conserved innate pathways upstream of adaptive immunity; and iii) shift focus to controlled clinical trials of potential vaccine adjuvants and determine how host environmental factors, different adjuvants, and different vaccine platforms compare against each other.

Inherent discrepancies with methods evaluating COVID-19 vaccine effectiveness and effect of the microbiome, and dietary variations

Firstly, these measurements are taken after a few months of receiving the primary vaccination regimen, based on the assumption that a study participant has peak immune responses at that time.

Secondly, and more importantly, the COVID-19 vaccine platforms vary widely. For instance, the adenovirus-based vaccines induce lower but long-term antibody response; however, the messenger ribonucleic acid (mRNA)-based Moderna vaccine, because of a higher dose and a longer dosing interval between primary and the booster dose, induces a more durable humoral response. Many independent factors also contribute to the vaccine-induced heterogeneity in the antibody and cellular responses.

Although several mechanisms control factors that shape vaccine effectiveness, of particular interest are the variations in the microbiome of individuals, microbial products, and other metabolites as they hugely impact both innate and adaptive immune responses to COVID-19 vaccines. More specifically, they modulate epigenetics, the intrinsic, innate antiviral immunity (IIAVI), and the innate immune response to impede the initial stages of viral infection and spread.

Furthermore, SARS-CoV-2 has invaded different geographic settings successfully, each endowed with a distinct environment wherein people have varied dietary habits that might affect vaccine efficacy. These factors, in the past, have modulated the immune responses to vaccination of pneumococcal disease and influenza. Similarly, with SARS-CoV-2, the prevalence of distinct viral variants in different geographies raises challenges about vaccine coverage and vaccine durability and argues for the potential development of regional vaccines.

Trained immunity guides the idea of personalized vaccines

Monocytes, macrophages, and DCs, after the first exposure to a pathogen, acquire ‘memory’, and activate pattern-recognition receptors (PRRs) on these cells leading to the upregulation of genes. An altered epigenetic landscape of these cells and enhanced accessibility of transcription factors to their related gene targets results in a potent and quicker immune response to future stimulation, essentially of T cell and B cell memory.

Studies have demonstrated that trained immunity enhanced immune responses with Bacillus Calmette–Guérin (BCG), diphtheria, tetanus, and pertussis (DTP) vaccines, and recently with the influenza vaccines. Hence, it could be the key to personalized vaccines for COVID-19.

Conclusions

Given the intra-platform variability in SARS-CoV-2 vaccine responses and efficacy, however, adopting holistic approaches is a must to define how individual variations in past and present microbial exposure modulate the establishment and maintenance of trained immunity and IIAVI.

To summarize, the authors recommended a holistic approach that would help develop a universal vaccine that would effectively combat and potentially eliminate all coronaviruses, including SARS-CoV-2 regardless of age, preexisting conditions, biological sex, ethnicity, and geographical locale.

This improvised and holistic approach would integrate all components that impact vaccine effectiveness to help get ahead of constantly mutating SARS-CoV-2.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: FOLIC ACID AND METHOTREXATE USE AND THEIR ASSOCIATION WITH COVID-19 DIAGNOSIS AND MORTALITY: AN ANALYSIS FROM THE UK BIOBANK. Image Credit: sfam_photo/Shutterstock

Study suggests folic acid supplementation linked to increased risk for COVID-19 diagnosis

by Medical Finance
May 23, 2022
0

In a recent study posted to the medRxiv* preprint server, researchers evaluated if folic acid or methotrexate use impacts the risk...

Study: SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated individuals. Image Credit: anushkaniroshan/Shutterstock

Superior immune response in vaccinated after infection with Omicron compared to unvaccinated

by Medical Finance
May 23, 2022
0

In a recent study posted to the medRxiv* preprint server, researchers evaluated the cross-reactivity of the severe acute respiratory syndrome coronavirus...

Study: SARS-CoV-2 Nsp1 N-terminal and linker regions as a platform for host translational shutoff. Image Credit: ATS / Shutterstock

Mechanism of SARS-CoV-2 Nsp1 interaction with ribosomal complexes

by Medical Finance
May 23, 2022
0

In a recent study posted to the bioRxiv* preprint server, the team of researchers explored the protein-protein interaction between the severe...

Study: Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19–Associated Hospitalization in Infants Aged <6 Months — 17 States, July 2021–January 2022. Image Credit: milkumistock / Shutterstock.com

Study shows mRNA COVID-19 vaccination in pregnancy can prevent hospitalization among infants

by Medical Finance
May 23, 2022
0

A report published in the CDC’s Morbidity and Mortality Weekly Report (MMWR) shows how primary two-dose vaccination series against coronavirus...

Study: Emergence of epidemic diseases: zoonoses and other origins. Image Credit: Rost9/Shutterstock

The emergence of infectious diseases from the “germ’s eye view”

by Medical Finance
May 23, 2022
0

In a recent study published in the latest issue of Faculty Reviews, researchers evaluated interactions of various microbiological, environmental, and social...

Study: How does the COVID-19 fuel insomnia?. Image Credit: Prostock-studio/Shutterstock

the relationship between COVID-19 and insomnia

by Medical Finance
May 23, 2022
0

In a recent review published in the journal Brain, Behavior, & Immunity – Health, researchers explored the links between coronavirus...

Next Post
‘Lefty’ protein pumps the brakes during initial stages of embryo differentiation

Using 'off-the-shelf' engineered stem cell based therapy for treating glioblastomas post-surgery

VANTAstar

Micro Products with Macro Impact; The Role of Microplate Readers in Life Sciences

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Sample management specialists win Queen’s Award for Enterprise
    Sample management specialists win Queen’s Award for Enterprise
  • futuristic techno design on background of supercomputer data center Image Timofeev Vladimir M1 402c068791b640469e416c4f55d84afe 620x480
    AI-driven solution predicts RNA and DNA binding sites to accelerate rational drug discovery
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply